Position in CCCC
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$8,130,418
+$5,341,748 QoQ
Shares Held
1,740,989
+64.2% QoQ
Ownership
1.42%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#21
of 147 holders
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CCCC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026D. E. Shaw & Co., Inc. holds $5,017,559,982 across 217 Biotechnology names. CCCC ranks #82 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
5,877,959 | $626,707,987 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,104,109 | $332,369,932 | |
| 3 | EXEL |
Exelixis, Inc.
|
5,551,747 | $302,070,554 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
3,633,007 | $270,586,360 | |
| 5 | TGTX |
Tg Therapeutics, Inc.
|
3,400,808 | $186,840,390 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
2,006,479 | $157,047,110 | |
| 7 | AXSM |
Axsome Therapeutics, Inc.
|
604,753 | $148,025,391 | |
| 8 | PTCT |
Ptc Therapeutics, Inc.
|
1,548,919 | $126,345,322 |
All Filings in CCCC
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,130,418 | 1,740,989 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $2,788,670 | 1,060,331 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $100,998 | 52,879 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $26,335 | 11,863 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $127,949 | 89,475 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $126,840 | 79,275 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $275,324 | 76,479 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $677,684 | 118,892 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $1,645,699 | 356,212 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $4,056,756 | 496,543 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $1,376,554 | 243,638 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $807,444 | 434,110 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $1,427,742 | 519,179 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $609,664 | 194,161 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $507,169 | 85,961 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $1,140,819 | 130,082 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $594,061 | 78,788 | Shares | Defined | 2022-08-15 | |
| 2021-12-31 | $828,667 | 25,735 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $441,572 | 9,883 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $625,570 | 16,532 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $200,855 | 5,430 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $416,576 | 12,574 | Shares | Defined | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||